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Our objective was to determine the effect of stress mediators such as 
inflammatory cytokines and β adrenergic agonists on developing skeletal muscle. Fetal 
sheep exposed to chronic maternal inflammation had decreased skeletal muscle glucose 
oxidation rates when stimulated with insulin or TNFα. In addition, activation of Akt by 
insulin was decreased after maternal inflammation when compared to controls and there 
were not differences in skeletal muscle fiber type ratios between the two treatment 
groups. This indicates that maternal inflammation does not affect overall oxidative 
capacity in the developing fetus, but rather insulin signaling pathways are disrupted.   
 We sought to determine whether the metabolic response to β adrenergic and 
insulin stimulation previously shown in mature skeletal muscle is a phenotypic trait 
passed to the mature muscle from developing muscle stem cells. Bovine myoblasts were 
differentiated in media containing either β1 adrenergic agonist +/- insulin or β2 
adrenergic agonist +/- insulin. Glucose oxidation was increased in the myoblasts 
simulated by β2 adrenergic agonist compared to myoblasts stimulated by β1 adrenergic 
agonists suggesting that the β2 adrenergic agonist is more effective at enhancing glucose 
metabolic efficiency than the β1 adrenergic agonist. Furthermore, we determined that 
when stimulated by β2 adrenergic agonist and insulin, myoblasts had decreased glucose 
 
 
oxidation rates compared to insulin alone. This is opposite of the effects seen in a similar 
study conducted utilizing mature skeletal muscle, indicating that this response is not 
necessarily derived from the muscle stem cell.  
 In a final study, we evaluated mitochondrial respiration rate in bovine myoblasts 
from cows that had been classified as having either High or Low concentrations of 
androstenedione (A4) in their follicular fluid. Calves born to cows classified as High A4 
had increased weaning weights compared to calves born to cows classified as Low A4. 
By performing a mitochondrial stress test using an XF-96 Seahorse Bioanalyzer, we were 
able to measure cellular respiration. We hypothesized that myoblasts from the High A4 
cows would have enhanced metabolic efficiency compared to the Low A4 cows. 
However, we found no differences in mitochondrial oxidation rates among treatments but 
did find a tendency (P = 0.1) for muscle stem cells from High A4 cows in the absence of 
insulin and from Low A4 cows when insulin was present to have increased rates of 
glycolysis. This indicates that the enhanced growth efficiency of the calves born to the 
High A4 cows is likely due to a different biological mechanism.  
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Chapter 1 
Literature Review 
Introduction 
Intrauterine Growth Restriction 
Placental insufficiency can be defined as a smaller or functionally stunted 
placenta that limits the flow of nutrients from mother to fetus, leading to intrauterine 
growth restriction (IUGR) (Molteni et al., 1978; Marconi et al., 2006; Alisi et al., 2011). 
In the United States, IUGR is clinically defined as birth weight that falls below the 10th 
percentile for an infant’s gestational age (Morrison, 2008). Infants born small for 
gestational age (SGA) have an increased risk of developing metabolic syndrome later in 
life, abnormal partitioning of dietary nutrients (Brodsky and Christou, 2004), and an 
increase in perinatal and neonatal morbidity and mortality (Pollack and Divon, 1992; 
Brodsky and Christou, 2004; Tuuli et al., 2011).  
Impact of IUGR on Life Quality  
Perinatal Morbidity and Mortality  
Developmental adaptations due to IUGR have detrimental effects on infants 
during the perinatal period. This includes increased risk of hypoglycemia, hypothermia, 
chronic lung disease, and impairment of renal function (Chiswick, 1985). In addition, 
many neonatal complications resulting from IUGR lead to death. 
Childhood and Adult Disease  
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IUGR also increases the risk of developing metabolic dysfunction, which can 
substantially reduce the quality of life in humans because it leads to multiple health 
issues. IUGR-induced metabolic dysfunction has been associated with an increased risk 
of developing cardiovascular disease, type II diabetes, and predisposition to central 
obesity; each of these factors increase the risk of morbidity and mortality (Gallagher et 
al., 2011). Obese patients due to metabolic dysfunction can experience fatigue and an 
increase in appetite stimulation, both of which contribute to further weight gain 
(Gallagher et al., 2011). Furthermore, patients with central obesity have a higher risk of 
developing fatty liver disease than patients with lower body fat (Grundy, 2000). Studies 
have also shown that patients with obesity are more likely to develop certain cancers 
including colon, breast, and prostate cancer (Grundy, 2000). Patients with metabolic 
dysfunction require aggressive, long-term medical treatment in order to manage the risk 
of chronic diseases such as cardiovascular disease and type II diabetes (Gallagher et al., 
2011). In fact, metabolic complications of diabetes costs an estimated $2.4 billion in 
annual direct medical expenses (Kitabchi et al., 2009). The incidence of obesity and other 
conditions related to metabolic dysfunction is increasing globally and is expected to 
affect 40% of the world’s population by 2025 (Rinaudo and Wang, 2012). As many as 
half of all clinical cases of metabolic disease are believed to be predisposed by IUGR 
(Vonnahme, 2012). By understanding the underlying mechanisms, the incidence of 
metabolic syndrome could be reduced in the future.  
Impact of IUGR on Livestock Efficiency  
In meat animals, a high proportion of muscle is critical because meat is the 
profitable product (Irshad et al., 2013). However, IUGR results in a decrease in muscle 
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growth due to adaptive fetal programming in response to restriction of nutrients. In fact, 
nutrient restriction from early to mid-gestation has been shown to reduce muscle fiber 
number in fetuses (Zhu et al., 2004). Furthermore, IUGR-induced low birth weight in 
livestock species can lead to increased perinatal mortality due to reduced vigor 
(Greenwood and Bell, 2002). Skeletal muscle makes up about 40% of the body’s mass 
and plays a critical role in metabolism (DeFronzo et al., 1981). Consequently, as IUGR-
induced low birth weight offspring mature, these animals develop a greater fat-to-muscle 
ratio and have reduced lean muscle mass (Yates et al., 2012), leading to a decrease in 
carcass quality, yield, and profit for the producer. Therefore, by understanding the 
underlying mechanisms linking IUGR and poor muscle growth efficiency, carcass quality 
and yield in low birth weight livestock could be improved, resulting in greater profit for 
the producer.  
Metabolic Syndrome  
Metabolic syndrome is a human condition defined by the clinical diagnosis of 
three out of the following five metabolic characteristics; insulin resistance, hypertension, 
central obesity, increased triglyceride concentration, and decreased high density 
lipoprotein concentration (Gallegher et al, 2011). This manuscript focuses on insulin 
resistance, central obesity, and hypertension.  
Insulin Resistance  
Clinically defined as a reduction in biological response to insulin secretion 
(Cefalu, 2001), insulin resistance is a known constituent of metabolic syndrome that is 
often a result of stress-induced adaptive fetal programming (Hales and Barker, 2001; 
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Gallagher et al., 2011). Insulin resistance manifests to type II diabetes when insulin is no 
longer secreted at a high enough concentration to compensate for the lack of insulin 
action due to reduced sensitivity (Reaven, 2005). Metabolic adaptations that contribute to 
the development of insulin resistance in IUGR individuals include reduced skeletal 
muscle mass and disruptions in insulin signaling pathways (Ozanne et al., 2005). Fetal 
stress responses result from placental insufficiency and mediate nutritional thrift in order 
to spare available nutrients for the most critical tissues to aid fetal survival. However, 
when the IUGR individual is born into an environment where nutritional thrift is no 
longer necessary and the mechanism has been programmed, insulin resistance is more 
likely to develop due to typical calorie intake combined with thrifty energy expenditure 
(Hales and Barker, 2001).  
Central Obesity 
Another characteristic of metabolic syndrome is central obesity. Obesity is 
clinically defined as body mass index (BMI) >30 kg/m2 (Gallagher et al., 2011) as 
opposed to clinically overweight which is defined as BMI >27.8 for males and >27.3 for 
females (Van Itallie, 1985). Central obesity, or excessive truncal fat (Klein et al., 2007),  
is indicative of adaptive fetal programming that disrupts metabolic function. IUGR-born 
infants experience postnatal “catch-up” growth (Vaag, 2009), a period during early life in 
which rapid weight gain occurs (Law et al., 2002). However, this has negative effects on 
metabolic health later in life due to accelerated weight gain from fat deposition rather 
than skeletal muscle accretion (Vaag, 2009). This is problematic in livestock production 
as well, since animals develop greater fat-to-muscle body composition, resulting in lower 
yield and meat quality (Irshad et al., 2013). 
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Hypertension  
Up to 85% of patients with metabolic dysfunction develop hypertension (Duvnjak 
et al., 2008), which is clinically defined as blood pressure of  ≥140/90 mmHg systolic 
over diastolic, respectively (Gallagher et al., 2011). Hyperinsulinemia resulting from 
insulin resistance elevates blood pressure, leading to sodium retention and volume 
expansion (Duvnjak et al., 2008). Obese individuals tend to have increased blood 
pressure, also leading to volume expansion and an increase in cardiac output (Grundy, 
2000). Hypertension due to insulin resistance and obesity further manifests into vascular 
damage (Duvnjak et al., 2008), cardiovascular disease, stroke, heart failure, and renal 
failure (Grundy, 2000). 
 
The “Thrifty Phenotype Hypothesis” 
Adaptive Fetal Programming 
About 25 years ago, David J.P. Barker first published his Thrifty Phenotype 
Hypothesis which described the epidemiological link between individuals who are born 
small for gestational age (SGA) and their increased risk of developing metabolic 
syndrome later in life (Hales et al., 1991; Hales and Barker, 1992; Barker et al., 1993). 
The Thrifty Phenotype Hypothesis suggests that the link between stress induced low birth 
weight and the increased risk of developing metabolic syndrome results from fetal 
adaptations to stress, resulting from a decrease in available nutrients that lead to 
programmed alterations in glucose metabolism (Hales and Barker, 2001). Fetuses are 
extremely responsive to their environment which can greatly influence their 
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development, and developmental plasticity is reduced drastically after birth (Gluckman 
and Hanson, 2004). Development of thrifty metabolic rates leads to more dietary 
nutrients being directed toward storage as fat rather than being used for muscle accretion 
or energy production. (Barker, 1998; Hales and Barker, 2001) Thrifty adaptive 
programming is beneficial during gestation, however, it greatly increases the risk of 
developing metabolic diseases in childhood and adulthood (Yates et al., 2012) including 
metabolic syndrome (Barker et al., 1993). This is due to the inability for IUGR-born 
individuals to cope with a different nutritional environment after birth (Rinaudo and 
Wang, 2012). Since the postnatal diet is typically not limited, IUGR-born individuals 
develop excess fat and not enough skeletal muscle due to restriction of nutrient and 
oxygen transport during development (Bauer et al., 1998). Epidemiological studies 
overwhelmingly support a link between IUGR and the increased risk of developing 
metabolic syndrome (Barker, 1998; Hales and Barker, 2001). In fact, IUGR-born 
offspring are 18-times more likely to develop metabolic syndrome than offspring born at 
appropriate size for gestational age (Gatford et al., 2010). However, the underlying 
mechanisms explaining the link between IUGR fetuses and the increased risk of 
developing metabolic syndrome is still unknown (Hales and Barker, 2001; Vaag, 2009). 
Maternal Stressors and Fetal Stress  
The most common maternal stressors associated with IUGR in humans include 
illness, nutritional deficiencies, and exposure to toxins during pregnancy (Rinaudo and 
Wang, 2012) such as the use of drugs, smoking, or alcohol. The most common maternal 
etiologies in livestock include environmental stressors such as heat, cold, or altitude 
stress (Yates et al., 2011) as well as  nutritional stress (Vonnahme, 2012). All of these 
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stressors can cause placental stunting by reducing uterine blood flow (Bell et al., 1987) 
(Figure1). Changes in placental vasculature caused by placental stunting limit the 
umbilical vein and fetal artery’s ability to receive oxygen and nutrients (Greenwood and 
Bell, 2002; Regnault et al., 2007; Vonnahme, 2012). This results in a chronically hypoxic 
and hypoglycemic fetus later in gestation (Greenwood and Bell, 2002). As fetal 
hypoxemia and hypoglycemia worsen, hypercatecholaminemia and hypoinsulinemia 
develop in turn, since adrenal secretion of catecholamines work towards maintaining fetal 
glucose supply by suppressing insulin secretion (Leos et al., 2010). The comprehensive 
adaptations due to fetal stress are still unknown, but understanding the mechanisms 
involved is the first step to finding a way to prevent or treat the effects of maternal stress 
on the developing fetus.  
 
Characteristics of IUGR Pathology 
Sheep as a Model for Placental Insufficiency-Induced IUGR   
Using animals as a model for biomedical research is advantageous because it 
allows researchers to assess the effects of a particular stress applied over a certain time 
period in a more controlled setting. Rodent and sheep models are the most common 
models used for fetal biomedical research. The rodent model has advantages such as 
lower cost and rapid gestation period. However, sheep physiology more closely 
resembles human physiology, including metabolic function, nutrient transport, and 
developmental milestones and critical periods (Barry and Anthony, 2008). Furthermore, 
the ewe can be selected for one fetus as opposed to a litter of offspring such as rodents 
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(Green et al., 2011; Rinaudo and Wang, 2012). Sheep also allow researchers to monitor 
placental exchange as well as fetal physiology in utero in the conscious animal due to the 
ability of the fetus to tolerate catheterization of fetal blood vessels that allows frequent, 
real-time sampling from the conscious animal in utero. These characteristics make the 
pregnant sheep a valuable model for human biomedical research (Barry and Anthony, 
2008; Green et al., 2011). 
The Role of Skeletal Muscle in IUGR Adaptations 
Sufficient skeletal muscle mass plays an important role in glucose homeostasis 
and the metabolic health of an individual. Skeletal muscle makes up ~40% of the body’s 
mass (Yates et al., 2012) and accounts for  greater than 80% of all insulin stimulated 
glucose utilization (DeFronzo et al., 1981) and thus skeletal muscle plays a major role in 
glucose homeostasis (Yates et al., 2012).  However, placental insufficiency is known to 
cause a reduction in fetal muscle mass due to the disruption of myogenesis (Yates et al., 
2012; Yates et al., 2014; Yates et al., 2016). This reduction in muscle mass carries into 
adulthood and is known to have an impact on muscle strength (Inskip et al., 2007; 
Ylihärsilä et al., 2007). Furthermore, there are strong correlations between IUGR, 
insufficient muscle mass, and the development of insulin resistance, which leads to the 
development of type II diabetes and the metabolic syndrome (Hales et al., 1991; Hales 
and Barker, 2001). However, the origins of decreased muscle growth and metabolic 
dysfunction in IUGR fetuses and IUGR-born offspring at the cellular level are not 
presently understood, but the characterized pathologies are described in Figure 2. 
Effects of IUGR on Skeletal Muscle Mass  
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IUGR results in asymmetric growth due to disproportional reduction of muscle 
mass and an increase in adipose tissue deposition after birth (De Blasio et al., 2007) 
because skeletal muscle growth continues to be much slower in individuals born IUGR. 
Ultrasonic measurements of IUGR fetuses show reduced muscle mass when compared to 
non IUGR fetuses (Galan et al., 1999). Furthermore, IUGR individuals are not only likely 
to have impaired muscle growth capacity, but also store more energy in adipose tissue as 
a result of thrifty programming.  Having less muscle mass is an advantage for these 
fetuses because skeletal muscle is a major consumer of glucose, which the fetus requires 
for normal development and function of neural, cardiac, and endocrine tissues (Klip and 
Pâquet, 1990).  
Myoblast/Myofiber Dynamics  
During the early development of muscle, mononuclear muscle stem cells called 
myoblasts proliferate, differentiate, and fuse into multinuclear myofibers (Yates et al., 
2012). During early gestational development, embryonic myoblasts fuse and form 
primary myofibers which provide scaffolding for myoblast facilitated formation of 
secondary myofibers (Yates et al., 2012; Brown, 2014) (Figure 3). Secondary myogenesis 
occurs during mid-gestation. This involves proliferation of the fetal myoblasts which is 
followed by expression of muscle regulatory factors (MRFs). Myofibers grow by 
increasing in diameter and length, in a process known as hypertrophy. Hypertrophy is 
mediated by activation and fusion of satellite cells with existing fibers and is the only 
form of muscle growth after birth, since myofiber numbers can no longer increase (Allen 
and Rankin, 1990). Myogenic markers such as Pax7, MyoD, and Myogenin can be used 
to identify the stage at which myoblasts are at in their cycle. IUGR can have a negative 
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impact on muscle development by disrupting this process, however the molecular 
mechanisms remain to be understood. Pax7 is present in both fetal and postnatal skeletal 
muscle (Hutcheson et al., 2009) and is expressed prior to differentiation (Zammit et al., 
2006). During proliferation, myoblasts express MyoD (Gillespie et al., 2009) and 
continue to express as they exit the cell cycle and enter terminal differentiation (L'honore 
et al., 2007). This leads into an increase in expression of Myogenin, the regulatory factor 
that promotes fusion of myoblasts into myofibers (Edmondson and Olson, 1989). 
Effects of IUGR on Skeletal Muscle Metabolic Rates  
IUGR individuals have a higher risk of developing metabolic dysfunction than 
non IUGR individuals. IUGR fetuses have altered metabolic rates because it allows them 
to survive a harsh uterine environment. Insulin stimulated glucose uptake rate is greatest 
in type I muscle fibers because this fiber type has the greatest insulin sensitivity (Lillioja 
et al., 1987). IUGR fetuses are known to have diminished type I fiber to type II fiber 
ratios, leading to unfavorable consequences in glucose homeostasis (Yates et al., 2016). 
This insulin resistance leads to a loss of glucose homeostasis in adulthood (Ozanne et al., 
2005). Furthermore, a reduction in type I muscle fibers is known to reduce glucose 
oxidation rates (Yates et al., 2012). Additionally, IUGR fetuses are characterized by 
hyperlactatemia (Jones and Ritchie, 1978; Maeda and Koos, 2009). Increased 
concentrations of catecholamines and acute hypoxemia during fetal stress causes a shift 
in metabolism from aerobic to anaerobic metabolism, resulting in increased lactate 
production (Limesand et al., 2007; Yates et al., 2012; Brown et al., 2015).    
Type I Muscle Fibers Are Most Impacted by IUGR  
11 
 
In healthy individuals and livestock (Wilson et al., 1992), there is a natural shift 
from type II to type I muscle fibers throughout late gestation and in the first few months 
of life, however, IUGR may inhibit this shift and thus decrease metabolic plasticity 
(Yates et al., 2016). IUGR is predictive of a disproportional decrease in skeletal muscle 
mass throughout life. This is especially evident in muscles that are composed of type I 
muscle fibers, including soleus (De Blasio et al., 2007). Type I muscle fibers generally 
have the highest oxidative capacity, larger amounts of GLUT4, increased β adrenergic 
receptors which make them more likely to be impacted by the chronic stress response 
(Yates et al., 2012), and are especially prone to insulin insensitivity (Yates et al., 2016). 
Thus, greater nutrient sparing results when the type I muscle fiber proportion is 
disproportionately reduced relative to type II. Muscle fiber number is set before birth in 
most species, and there is no increase in muscle fiber number once an individual is born 
(Zhu et al., 2006; Yates et al., 2012; Brown, 2014). It is thought that nutrient restriction to 
the muscle fibers is linked to the predisposition of individuals born as a result of IUGR to 
the development of type II diabetes (Zhu et al., 2006).  
Reduced Insulin Sensitivity  
IUGR causes a reduction in the offspring’s insulin sensitivity, resulting in insulin 
resistance and eventually type II diabetes (Limesand et al., 2007). Insulin resistance is the 
metabolic state wherein peripheral tissues, especially skeletal muscle, have a reduced 
response to the effects of insulin and therefore glucose uptake rate by the cells is 
diminished (Dunlop et al., 2015). Skeletal muscle is most impacted by reduced insulin 
sensitivity because it accounts for greater than 80% of the body’s insulin stimulated 
glucose utilization (DeFronzo et al., 1981). Insulin acts by binding to its tyrosine kinase 
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receptor on the cell surface, which ultimately promotes translocation of GLUT4 to the 
surface of the cell. Autophosphorylation of tyrosine kinase, which catalyzes the 
phosphorylation of IRS1 and in turn Akt, results in the regulation of glucose uptake 
(Saltiel and Kahn, 2001). Previous studies have shown that the expression of the insulin 
receptor is actually increased in IUGR fetuses (Limesand et al., 2007), which is thought 
to be a compensatory mechanism for the decrease in circulating fetal insulin. However, 
expression of the receptors was not different in IUGR versus normal birth weight 
offspring, indicating that insulin resistance later in life results from a downstream defect 
of the receptor which alters the function of GLUT4 (Dunlop et al., 2015). 
 
Skeletal Muscle Glucose Homeostasis 
IUGR Blood Glucose Concentrations  
Glucose is the primary energy substrate utilized by the fetus for normal growth 
and metabolism (Hay, 2006) and thus the latter is dependent on fetal plasma glucose 
concentration. Skeletal muscle adapts in response to glucose concentration (Yates et al., 
2016). In a chronically hyperglycemic condition, there is a reduction in GLUT4 as well 
as other insulin signaling components (Limesand et al., 2007) in skeletal muscle which 
correlates with the development of insulin resistance later in life (Hay, 2006; Dulloo, 
2008). A reduction in GLUT4 transporters in skeletal muscle cells reduces insulin 
sensitivity, resulting in a continuous state of hyperglycemia in adults (Dunlop et al., 
2015). In hypoglycemic conditions, insulin responsive tissues are known to adapt using 
mechanisms such as increased insulin action and regulation of glucose transporter 
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concentrations that promote glucose utilization (Limesand et al., 2007). However, 
glucose transporter concentrations are not different between IUGR and normal 
birthweight individuals later in life (Dunlop et al., 2015). 
Glucose Uptake and Metabolism  
Glucose uptake and glucose oxidation play independent roles in an individual’s 
metabolic rate. Glucose uptake is when glucose molecules are brought into the cells by 
insulin sensitive GLUT4 and other GLUT transporters (Saltiel and Kahn, 2001; Leney 
and Tavaré, 2009). There are multiples types of GLUTs that have different specificities, 
kinetic properties, and expression profiles (Wood and Trayhurn, 2003). However, 
GLUT4 is insulin stimulated (Abel et al., 2001; Saltiel and Kahn, 2001). A wide variety 
of metabolic pathways follow glucose uptake such as glycolysis. Pyruvate is synthesized 
during this process. Pyruvate formed during glycolysis is oxidized to acetyl-CoA which 
then enters the citric acid cycle (Nelson and Cox, 2008, pg. 616). Insulin-stimulated 
glucose uptake and oxidation are presumed to be proportional, however, the presence of 
stress factors such as inflammatory cytokines may alter these metabolic functions 
(Cadaret et al., 2017b). In fact, IUGR fetuses are known to have lower glucose oxidative 
metabolism (Yates et al., 2012). By performing glucose uptake and oxidation studies, 
researchers are able to further their understanding of how acute and chronic stress factors 
change metabolic rates.  Increased circulating catacholamines and decreased insulin 
concentrations in IUGR fetuses in concert contribute to hyperlactatemia which may be 
caused by reduced glucose oxidation in the skeletal muscle in order to spare glucose and 
oxygen for vital tissues such as the brain. Prolonged durations of skeletal muscle nutrient 
and oxygen deprivation causes a metabolic shift. Therefore, adaptations to fetal 
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catecholamine concentrations in utero may explain this shift from oxidative metabolism 
to anaerobic glycolysis (Yates et al., 2012) (Figure 4). Furthermore, anaerobic glycolysis 
in meat producing animals is unfavorable due to a decrease in pH caused by lactate 
production which is known to effect meat quality attributes including water holding 
capacity, color, and juiciness (Andersen et al., 2005). 
 
Inflammatory Component of the Stress Response 
Introduction to Cytokines  
Pro-inflammatory cytokines such as IL-6 (Interleukin-6) and TNFα (Tumor 
Necrosis Factor) play a critical role in the inflammatory response of IUGR (Bartha et al., 
2003). These cytokines are predominantly produced by macrophages and participate in 
the up-regulation of inflammatory reactions (Zhang and An, 2007). In addition to pro-
inflammatory cytokines, there is another group of cytokines known as the anti-
inflammatory cytokines including IL-1, IL-4, IL-10, IL-11, and IL-13. (Zhang and An, 
2007).  Pro-inflammatory cytokines are associated with skeletal muscle degeneration 
during states of chronic stress (Späte and Schulze, 2004), while anti-inflammatory 
cytokines are immunoregulatory molecules that regulate the response of the pro-
inflammatory cytokines by inhibiting their function. The inflammatory and metabolic 
systems are closely linked which is advantageous under certain conditions. For example, 
an organism may need to redistribute its energy sources during an inflammatory response 
(Dionne et al., 2006). Furthermore, the pro-inflammatory cytokine TNFα is highly 
expressed in adipose tissue (Hotamisligil et al., 1993) and also plays a role in disrupting 
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insulin signaling pathways when activated (Uysal et al., 1997). Elevated concentrations 
of inflammatory cytokines under stressful conditions mediate proteolysis so that available 
amino acids provide fuel to the liver rather than skeletal muscle, resulting in an inhibition 
of muscle growth (Klasing and Johnstone, 1991). Therefore, inflammatory cytokines play 
major roles in both metabolism and muscle growth in IUGR individuals.  
Cytokine Signaling  
The major cytokine signaling pathways have been reviewed in detail by O’Shea et 
al. 2002 (Figure 5). The cytokine signaling pathway begins when inflammatory cytokines 
bind to homodimeric or heterodimeric receptors. These receptors bind to Janus kinases 
(JAKs) which phosphorylate the cytokine receptors. This phosphorylation allows signal 
transducers and activators of transcription (STAT) to bind. STAT is then phosphorylated 
and translocated to the nucleus of the cell where it binds to DNA and functions to 
regulate gene expression. More specifically, TNFα activates the transcription factor 
NFκB (Van Antwerp et al., 1996). Furthermore, cytokines can be regulated by 
stimulation of the proteins SOCS. SOCS can then inhibit cytokine signaling by binding to 
and inhibiting JAK/STAT.  
Long Term Effects of Inflammatory Cytokines  
The combined increased levels of IL-6 and IL-1β in an acute-phase response 
increases the risk of developing type II diabetes three-fold (Spranger et al., 2003). Studies 
have shown that chronically increased levels of IL-6 are associated with an increased risk 
of developing type II diabetes (Pickup and Crook, 1998). Both IL-6 and IL-1β act on the 
liver to produce characteristics of metabolic syndrome such as insulin resistance (Pickup 
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and Crook, 1998), and skeletal muscle which causes atrophy during states of chronic 
stress (Späte and Schulze, 2004). In addition, studies have shown increased levels of 
amniotic (Kupferminc et al., 1994) inflammatory cytokines in cases of IUGR (Heinig et 
al., 2000; Holcberg et al., 2001; Alisi et al., 2011). Elevated concentrations of 
inflammatory cytokines in amniotic fluid have been linked to irregular immune 
activation, leading to the pathophysiology of IUGR (Bartha et al., 2003). Studies suggest 
that administration of bacterial lipopolysaccharide (LPS) endotoxin to induce maternal 
inflammation in the second half of pregnancy reduced fetal weight significantly in rats 
when compared to control dams treated with saline (Cadaret et al., 2017a), suggesting 
that systemic maternal inflammation is impacting fetal weight by causing fetal 
inflammation. In conclusion, maternal inflammation correlates with a decrease in 
placental growth, particularly reduced thickness, and a decrease in length and area, 
(Cotechini et al., 2014), which is known to cause smaller postnatal body size and 
development of metabolic deficiencies later in life (Barker et al., 2010). The chronic 
effects of pro-inflammatory cytokines are complex and are linked to the development of 
insulin resistance (Marette et al., 2014), which ultimately manifests in metabolic 
syndrome (Dandona et al., 2005). 
Nonsteroidal Anti-Inflammatory Drugs and Pregnancy 
 Fetal exposure to inflammatory cytokines during gestation leads to metabolic 
adaptations that can be detrimental after birth and into adulthood such as insulin 
resistance and obesity (Pickup and Crook, 1998). NSAIDS (nonsteroidal anti-
inflammatory drugs) are used to treat inflammatory responses by inhibiting 
cyclooxygenase (Østensen, 1996). Pregnant women are currently discouraged from 
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taking NSAIDS. The use of NSAIDS during pregnancy is thought to cause miscarriage 
(Li et al., 2003), intracranial hemorrhaging (Rumack et al., 1981), and renal failure 
(Cantor et al., 1980). However, there have been minimal studies conducted on fetal 
exposure to NSAIDS (van Gelder et al., 2011). 
 
Elevated Steroid Concentrations and Gestation 
Polycystic Ovary Syndrome 
 Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 5-10% of 
females of reproductive age (Franks, 1995). Females with PCOS experience ovarian 
cysts, irregular menstrual cycles, and hyperandrogenism. Furthermore, PCOS is 
accompanied by metabolic deficiencies such as insulin resistance and obesity (Faloia et 
al., 2004). Elevated androgen levels seen in females with PCOS remain even during 
pregnancy (Sir-Petermann et al., 2002). Androgens including testosterone can reduce 
fetal and newborn growth in offspring from females with hyperandrogensim (Carlsen et 
al., 2006).  
Effects of Elevated Androgen Levels on Fetal and Newborn Growth 
 Exposure to excess androgens during critical periods of gestation can lead to 
reduced birth weight (Carlsen et al., 2006) and metabolic deficiencies in offspring (Smith 
et al., 2009). Female fetuses exposed to elevated testosterone during gestation have 
impaired insulin secretion and increased adiposity later in life (Eisner et al., 2000). In 
ewes, prenatal exposure to elevated testosterone levels causes IUGR (Steckler et al., 
2005). Recent studies indicate that exposure to androgens during fetal development 
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induces metabolic deficits which may be due to programming of metabolic pathways 
(Abbott et al., 2005). 
Conclusion 
It is well known that maternal stress has adverse effects on the development of a 
fetus’s muscle growth and metabolic function leading to the development of metabolic 
syndrome later in life. Evidence suggests that maternal inflammation is causing fetal 
inflammation either directly or indirectly by causing placental insufficiency. Pregnant 
women are currently discouraged from taking NSAIDS because it has been shown to 
cause unfavorable neonatal outcomes (Cantor et al., 1980; Rumack et al., 1981; Li et al., 
2003). However, the aim of current research is to understand whether chronic 
inflammation during pregnancy is more damaging to the fetus than the effects of 
NSAIDS that treat chronic inflammation. By understanding the underlying mechanism 
causing fetal inflammation, we will be able to better address the pathophysiology and 
prevention of long-term metabolic diseases in humans and livestock, improving quality of 
life. More specifically directed towards livestock production, increased meat quality and 
profit for the producer can be achieved.  
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Figure 1. Maternal stressors lead to adaptive fetal changes in growth and metabolism 
by stunting the placenta. Placental insufficiency ultimately leads to fetal inflammation 
by causing hypoxemia, hypoglycemia, hypercatacholaminemia, and hyperinsulinemia. 
The perinatal effects of these factors include hypertension, asymmetric growth, and 
insulin resistance. 
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Figure 2. During conditions of placental insufficiency, fetal muscle mass is greatly impacted. 
A reduction in fetal muscle mass will ultimately lead to an increased risk of developing 
metabolic deficiencies later in life due to skeletal muscle being a primary tissue for glucose 
utilization.  
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Myoblast Proliferation Differentiation 
Figure 3. Activated myoblasts will proliferate, differentiate, and fuse and with myofibers. 
Each of these stages is characterized by expression of specific muscle regulatory factors 
(MRF) transcription factors.  
 
 
 
Fusion 
Pax7 MyoD Myogenin 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypercatecholaminemia 
Hypoxemia 
Oxidative Metabolism Anaerobic Glycolysis 
Lactate Production 
Figure 4. Hypercatecholaminemia and hypoxemia experienced during fetal stress causes a 
metabolic shift from aerobic glycolysis to anaerobic glycolysis, leading to excess lactate 
production. 
Hypoglycemia 
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Figure 5. Inflammatory cytokine signal transduction pathway. 
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Chapter 2 
Maternal inflammation in the pregnant ewe at 0.7 gestation impairs glucose 
oxidation in fetal skeletal muscle near term 
Abstract. Placental insufficiency caused by maternal stress during gestation is known to 
decrease birth weight and increase the risk of offspring developing metabolic deficiencies 
such as insulin resistance and obesity. However, the underlying mechanisms remain to be 
understood. Our objective was to determine if chronic maternal stress impairs subsequent 
glucose metabolism rates in fetal sheep near term. Pregnant ewes were treated with saline 
(controls) or bacterial endotoxin (LPS) every 3rd day from day 100-115 of gestation (term 
= 150 days) to induce systemic inflammation. On gestational day 125, ewes were 
euthanized and fetal soleus muscle was isolated tendon-to-tendon and split longitudinally. 
To determine glucose uptake and glucose oxidation rates, soleus strips were incubated in 
KHB (Krebs Henseleit Buffer) that was un-spiked (basal) or spiked with either insulin or 
TNFα. In addition, Akt phosphorylation in extensor digitorum longus muscle samples 
was determined by western immunoblot analysis and Myosin heavy chain (MyHC) 
content was determined using electrophoresis. Furthermore, fiber type numbers and sizes 
were determined from fetal semitendinosus sections by immunohistochemistry.  In 
primary fetal soleus muscle, glucose uptake was not different between control and 
maternal inflammation fetuses under basal, insulin-stimulated, or TNFα-stimulated 
conditions. However, insulin-stimulated glucose oxidation and TNFα-stimulated glucose 
oxidation were both greatly decreased (P < 0.05) in chronically stressed fetal muscle 
compared to controls. In addition, Akt phosphorylation was decreased (P < 0.05) after 
maternal inflammation when compared to controls. However, there were not differences 
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in MyHC content or skeletal muscle fiber number but Type IIx muscle fiber area was 
decreased (P < 0.05) after maternal inflammation when compared to controls. Our 
findings indicate that glucose metabolism in fetuses is impaired after chronic maternal 
inflammation which explains in part how stress-induced IUGR caused by maternal 
stressors increases the risk of insulin resistance in offspring. Phosphorylation of Akt in 
insulin cultures is diminished which indicates that decreased Akt phosphorylation is the 
mechanism causing impaired glucose metabolism rather than differences in skeletal 
muscle fiber proportions.   
Introduction 
Infants born small for gestational age as a result of IUGR are known to be at an 
18-fold greater risk for developing metabolic syndrome later in life (Gatford et al., 2010). 
Reduction in muscle mass contributes to reduced size at birth, as less muscle is 
advantageous for fetuses developing in a harsh uterine environment because limited 
nutrients can be redirected to more vital brain and heart tissues (Hales and Barker, 2001). 
Skeletal muscle accounts for greater than 80% of insulin-stimulated glucose metabolism 
(DeFronzo et al., 1981) and therefore plays a major role in glucose homeostasis (Yates et 
al., 2012).  
Insulin is known to increase glucose uptake in skeletal muscle by binding to its 
tyrosine kinase receptor and activating a signaling cascade that ends with the GLUT4 
transporter being translocated to the cell membrane, where it facilitates glucose transport 
into the cell. Akt phosphorylation is a critical step in the insulin signaling pathway that 
contributes to many of insulin’s effects on the cell (James et al., 1988). In this study, we 
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determined whether changes in glucose metabolism coincide with changes in Akt 
phosphorylation rates, which could help explain reduced insulin sensitivity.  
Inflammatory cytokines such as TNFα and IL-6 acutely stimulate skeletal muscle glucose 
oxidation similarly to insulin, despite disrupting insulin signaling (Cadaret et al., 2017b). 
However, chronic exposure to inflammation may reduce sensitivity to cytokines. We 
hypothesize that fetal muscle that has been chronically inflamed due to maternal 
inflammation during the third trimester of pregnancy will become less responsive to the 
stimulatory effects of inflammatory cytokines, which can ultimately lead to the 
development of insulin resistance (Pickup and Crook, 1998; Spranger et al., 2003). We 
speculate that stressed fetuses with reduced muscle mass will have a decrease in glucose 
uptake and oxidation when compared to controls.   
Materials and Methods 
Animals. The following experiments were approved by the Institutional Animal 
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted 
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by 
the American Association for Accreditation of Laboratory Animal Care. Animals used 
for this study included thirteen timed-bred Polypay ewes carrying ultrasound-verified 
twin pregnancies. Polypay ewes carrying twins received an IV injection of sterile saline 
(Controls; n = 8) or 0.1 μg/kg BW of bacterial lipopolysaccharide (LPS; n = 5) from E. 
coli O55:B5 (Sigma-Aldrich, St. Louis, MO) every third day from day 100 to 115 of 
gestation (term = 150 days) (Figure 1). 
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Glucose Uptake. Soleus muscle (100-500 mg) was utilized for this experiment 
due to its increased type I muscle fiber ratio, thus having high oxidative capacity. The 
muscle was isolated tendon to tendon during necropsy from fetal sheep at 125 dGA. Pre-
incubation, wash, and incubation media were spiked with the following treatments: none 
(basal), insulin (5 mU/ml Humulin-R), or TNFα (20 ng/ml hTNFα). All additives were 
purchased from Sigma-Aldrich (St. Louis, MO). Muscle strips were incubated at 37º C 
for 20 minutes in treatment spiked KHB with 1 mM [3H]2-deoxyglucose and 39 mM 
[14C] mannitol. Muscle strips were removed and washed thrice in ice-cold PBS, weighed, 
and lysed in 2 M NaOH at 37º C for 1 hour. Lysate was mixed with scintillation fluid and 
specific activity of [3H] and [14C] was measured. Specific activity of media was also 
determined.  
Glucose Oxidation. Muscle strips were placed in sealed dual-well chambers and 
incubated at 37º C for 2 hours in treatment-spiked KHB with 5 mM [14C-U] D-glucose. 2 
M NaOH was put into the adjacent wells to collect 14CO2. After the 2 hour incubation, the 
chambers were cooled at -20º C for 2 minutes. 2M HCl was injected into the media 
through the rubber seal. Chambers were placed at 4º C for 1 hour. Chambers were opened 
and muscle strips were washed and weighed. The NaOH was collected and mixed with 
scintillation fluid to determine the specific activity of 14CO2. Specific activity of media 
was also measured.   
Myosin heavy chain electrophoresis. Fetal extensor digitorum longus muscle 
(100-500 mg) was used due to its high oxidative capacity. The muscle was split 
longitudinally and muscle strips were incubated in insulin-spiked KHB for 20 minutes, 
snap frozen, and stored at -80ºC. The muscle strips were homogenized in 200 µl of RIPA 
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buffer containing manufacturer recommended concentrations of Halt Protease and Halt 
Phosphatase Inhibitor Cocktails (Thermo Fisher). Homoginates were sonicated and 
centrifuged (2,500 x g; 10 minutes). Supernatant was collected and total protein 
concentrations were determined by Pierce BCA Assay (Thermo Fisher). Samples were 
then incubated at room temperature for 10 minutes., heated at 70ºC for 10 minutes., 
combined with Bio-Rad 4X Laemmli Sample Buffer (Bio-Rad, Hercules, CA) to a 1X 
concentration, and loaded onto a separating gel at 15 µg/well. Myosin heavy chain 
isoforms were then separated by SDS-Page. The separating gel consisted of 35% 
glycerol, 9% acrylamide/bisacrylamide (50:1), 230mM Tris (pH 8.8), 115mM glycine, 
0.4% SDS, 0.5% TEMED, and 0.1% APS. The gel was poured between plates, overlaid 
with water, and allowed to polymerize for 10 minutes. After polymerization, water was 
removed using blot paper. Stacking gel consisted of 47% glycerol, 6% 
acrylamide/bisacrylamide (50:1), 110mM Tris (pH 6.7), 6mM EDTA, 0.4% TEMED, and 
0.1% APS. This gel was poured on top of the polymerized separating gel. The comb was 
inserted and gel was allowed to polymerize for 15 minutes. Protein samples were 
prepared by combining 15 µg of protein with 4X sample buffer (to 1X). Samples were 
incubated at room temperature for 10 minutes then put on a dry bath at 70ºC for 10 
minutes. To run the SDS-page, the comb was removed and wells were rinsed with water, 
wells were loaded at 15 µg/well, and gel was run at 100 volts for 30 hours at 4ºC. After 
electrophoresis, the SDS-Page was washed and stained with GelCode Blue Stain Reagent 
overnight. Samples were then imaged using an Odyssey infrared imaging system (LI-
COR Biosciences, Lincoln, NE). Myosin heavy chain I and myosin heavy chain II bands 
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were measured by densitometry (Image Studio Lite Ver 5.0; LI-COR) and normalized to 
total MyHC protein content. 
Western Immunoblot. The activation of Akt was estimated by the proportions of 
phosphorylated  to total Akt protein as previously described (Cadaret et al., 2017b), with 
minor modifications. Phosphorylated Akt and total Akt protein concentrations were 
determined in fetal extensor digitorum longus muscle strips that were incubated in 
insulin-spiked KHB for 20 minutes, snap frozen, and stored at -80ºC. Muscle strips (100-
500 mg) were homogenized in 200 µl of radioimmunoprecipitation buffer containing 
manufacturer-recommended concentrations of Protease and Phosphate Inhibitor (Thermo 
Fisher, Carlsbad, CA). Homogenates were sonicated and centrifuged (14,000g for 5 
minutes at 4ºC), then supernatant was collected. Total protein concentrations were 
determined by Pierce BCA Protein Assay Kit (Thermo Fisher). Protein samples were 
boiled for 5 minutes. at 95ºC in BioRad 4X Laemmli Sample Buffer (BioRad, Hercules, 
CA) then separated by SDS-polyacrylamide. Protein samples were diluted into 4X 
sample buffer (to 1X) and incubated at room temperature for 10 minutes. Samples were 
then put in a dry path at 70ºC for 10 minutes. Protein was loaded for electrophoresis and 
gel was run at 100 volts for 30 minutes at 4ºC. Gels were transferred to polyvinylidene 
fluoride low florescence membranes (BioRad) which had been incubated in Odyssey 
block solution (Li-Cor Biosciences, Lincoln, NE) for 1 hour at room temperature and 
washed with 1X TBS-T (20mM Tris-HCl + 150mM NaCl + 0.1% Tween 20). 
Membranes were then incubated with one of the following rabbit antibodies diluted in 
Odyssey block solution + 0.05% Tween-20: anti-phospho-Akt (Cell Signaling, Danvers, 
MA) (1:2000) for 1 hour at room temperature or anti-Akt (9272) (1:1000) at 4ºC 
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overnight. An IR800 goat anti-rabbit IgG secondary antibody (1:10,000) diluted in 
Odyssey block solution with 0.05% Tween-20 and 0.01% SDS was applied for 1 hour at 
room temperature. Blots were scanned on an Odyssey Infrared Imaging System and 
analyzed with Image Studio Lite Software (Li-Cor). For each protein of interest, 
phosphorylation rates were estimated by the proportions of phosphorylated protein to 
total protein.  
Immunohistochemistry. Isolated semitendinosus muscle was fixed in 4% PFA for 
48 hours, 30% sucrose for 24 hours, and 50:50 OCT: 50% sucrose mixture for 24 hours. 
A cross section of muscle was embedded in OCT (Fisher HealthCare, Houston, TX) and 
stored at -80ºC. Muscle tissue was then sectioned by cryostat and mounted on glass 
microscope slides at 8µm, two cross sections per slide, and stored at -80ºC. Before 
staining, slides were dried in an Isotemp Oven (Thermo Scientific, Waltham, MA) at 
37ºC for 30 minutes. and rehydrated in PBS+ (PBS with 0.5% Triton-X-100) 3 x 5 
minutes each. Slides were fully submerged in citric acid (10mM) and microwaved at 40% 
power 4 x 5 minutes each and cooled for about 1 hour and submerged in PBS+ 3 x 5 
minutes each. 50µl of NEN blocking agent (0.5% NEN) was used to cover each cross 
section and each tissue was overlaid with Parafilm (Bemis, Neenah, WI) and incubated 
for 1 hour at room temperature in a humidified container. One of the following primary 
antibodies diluted in PBS + 1% BSA were added to tissue sections to detect myosin 
heavy chain I or IIx: 0.2 µg/ml BA-D5 or 2 µg/ml 6H1, respectively Each tissue was also 
co-stained for Desmin (1:300, Sigma). Slides were incubated overnight at 4ºC in a 
humidified container. On the second day, slides were washed in PBS+ 3 x 5 minutes. 
each. One of the following secondary antibodies diluted in PBS + 1% BSA were added to 
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tissue sections to detect myosin heavy chain I or IIx: 1:2000 Alexa Fluor 594 IgG or 
1:2000 594 IgM (Cell Signaling, Danvers, MA), respectively. Slides were incubated for 2 
hours at room temperature in a humidified container. Slides were washed for 5 minutes in 
PBS+ then submerged in double distilled H2O 2 times for 5 minutes each. 100µl per slide 
of DAPI (1:1000 in double distilled H2O) (Sigma) was added and slides were incubated 
at room temperature for 4 minutes. Slides were washed in double distilled H2O for 5 
minutes and then 250 µl of 0.3% Sudan Black (Fisher Scientific, Waltham, MA) was 
added to each slide for 20 minutes at room temperature in a humidified container. Slides 
were washed in double distilled H2O 3 x 5 minutes each. Slides were then coverslipped 
with 100µl of Tris buffered mounting media (0.1M). Staining was visualized using 
Olympus CellSense Software to determine proportions and average cross-sectional areas 
of positively-stained fibers within muscle sections. 
Statistical Analysis. Data were analyzed by ANOVA using the GLM procedure of 
SAS (SAS Institute, Cary, NC). Glucose uptake and glucose oxidation data were 
analyzed as two different experiments, each with its own basal, insulin, and TNFα 
conditions. Two separate muscle strip from each fetus was exposed to each condition in 
the experiment and averaged. Fetus was the experimental unit (control, n=8, maternal 
inflammation, n=6). Glucose metabolic rates are normalized to muscle strip mass and 
presented as percentage change from basal conditions. Data are presented and means ± 
standard error.  
Results 
Glucose Uptake. Incubation with insulin increased (P < 0.05) glucose uptake in 
fetal soleus muscle from both control and after maternal inflammation by ~30% and 
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~26%, respectively (Figure 2). Moreover, glucose uptake rates in fetal muscle strips 
incubated with TNFα was increased (P < 0.05) in both control and after maternal 
inflammation by ~48% and ~28% from basal conditions, respectively, and was not 
different from muscle incubated with insulin for either treatment group.  
Glucose Oxidation. An interaction (P < 0.05) was observed between maternal 
treatment and incubation media for glucose oxidation (Figure 3). Incubation in media 
spiked with insulin increased (P < 0.05) glucose oxidation in fetal muscle from both 
treatment groups, but the increase was greater (P < 0.05) in fetal muscle from control 
fetuses than after maternal inflammation by ~19%. Moreover, when muscle from control 
fetuses was incubated with TNFα, glucose oxidation was ~69% greater (P < 0.05) than 
when incubated under basal conditions but less by ~12% (P < 0.05) than when incubated 
with insulin. Conversely, when muscle from fetuses after maternal inflammation was 
incubated with TNFα, glucose oxidation rates did not increase above basal conditions.  
Akt Phosphorylation. Insulin stimulated phosphorylation of Akt was decreased (P 
< 0.05) in the fetal muscle strips after maternal inflammation compared to controls and 
was not different from muscle incubated under basal conditions (Figure 4). Furthermore, 
there was no difference in Akt phosphorylation between fetal muscle strips from either 
treatment stimulated with TNFα compared to basal.  
Myosin Heavy Chain Expression. Proportions of Type I fibers and Type IIx fibers 
were identified by MyHC staining (Figure 5). There were no differences in fiber type 
numbers between fetal semitendinosus from control fetuses and after maternal 
inflammation for Type I or Type IIx fibers (Figure 6). Furthermore, there was a decrease 
(P < 0.05) in Type IIx fiber area by ~57% after maternal inflammation compared to 
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control fetuses (Figure 7). In addition, there was no difference in myosin heavy chain 
ratios between control and chronically stressed fetuses (Figure 8). 
Discussion 
In this study, we show that insulin responsiveness of glucose oxidation is 
impaired in fetal skeletal muscle after chronic maternal inflammation. This helps to 
explain how IUGR born individuals are at an increased risk of developing metabolic 
diseases, despite the fact that capacity for insulin-stimulated glucose uptake in fetal 
muscle was not affected by chronic maternal inflammation. Moreover, stimulation of 
glucose oxidation by inflammatory cytokines was diminished by fetal adaptations to 
chronic maternal inflammation, even after inflammation had been alleviated. 
Additionally, insulin-stimulated Akt activation was impaired in fetal skeletal muscle after 
chronic maternal inflammation, which shows that disruptions in insulin signaling are 
contributing to impaired glucose oxidation. Furthermore, we determined that reduced 
glucose oxidative capacity was not attributable to changes in fiber type proportions as 
these were not different between treatment groups. Interestingly, maternal inflammation 
did lead to smaller Type IIx fibers but not Type I fibers.  These findings may help to 
explain previous findings showing that chronic inflammation during fetal development 
increases the risk of developing insulin resistance later in life (Hotamisligil et al., 1993).  
This study also shows exposure of fetal skeletal muscle to chronic inflammation 
inhibits TNFα-stimulated glucose oxidation, which was observed in controls. Our 
previous studies show that acute exposure to inflammatory cytokines increases glucose 
oxidation in muscle even in the absence of insulin (Cadaret et al., 2017b). However, the 
present study shows that chronic exposure to inflammation during fetal development 
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decreases this metabolic response and that subsequent stimulation by cytokines does not 
produce greater glucose oxidation. Thus, the acute benefit of this metabolic regulator is 
lost even though other changes associated with cytokines such as insulin insensitivity 
likely still occur. 
Skeletal muscle fiber type ratios were not affected by chronic maternal 
inflammation. While fiber type number was not different between treatments, the area of 
Type IIx fibers was decreased after maternal inflammation compared to controls. This 
indicates that there is no difference in the inherent oxidative capacity between skeletal 
muscle of the two groups of fetuses per se, but rather a reduced capacity to respond to 
insulin. Insulin-stimulated fetal skeletal muscle showed a reduction in activation of Akt 
after maternal inflammation. This shows that the impaired response to insulin is 
associated with chronic stress at least in part due to inflammatory adaptations. Thus, 
impairment of downstream hubs such as Akt may be major contributors to the decrease in 
glucose oxidation in chronically stressed fetuses rather than diminished proportions of 
Type I oxidative fibers.  
In conclusion, our study shows that fetuses exposed to chronic maternal 
inflammation develop decreased insulin-stimulated glucose oxidation rates despite 
normal oxidative capacity as indicated by fiber type proportions. Rather, Akt activation 
by insulin is substantially decreased by chronic maternal inflammation. This suggests that 
the decreased oxidation rate stems from adaptive impairment in insulin signaling.  
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Figure 1.  Polypay ewes carrying twins received an IV injection of sterile saline 
(Controls; n = 8) or 0.1 μg/kg BW of bacterial lipopolysaccharide (LPS; n = 5) every 
third day from day 100 to 115 of gestation. 
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Figure 2. Glucose uptake in fetal soleus muscle strips after maternal inflammation 
during 20 minute incubations spiked with one of the following treatments: No additive 
(basal), Insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα), respectively. a,b 
means with differing subscripts differ (P<0.05).  
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Figure 3. Glucose oxidation in fetal soleus muscle strips after maternal inflammation 
during 120 minute incubations spiked with one of the following treatments: No 
additive (basal), Insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα), 
respectively. a,b,c means with differing subscripts differ (P<0.05). 
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Figure 4. Akt phosphorylation in fetal extensor digitorum longus muscle after chronic 
maternal inflammation stimulated by one of the following treatments: No additive (basal), 
insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα), respectively. a,b means with 
differing subscripts differ (P<0.05). 
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Figure 5. Immunostaining for fiber type in fetal semitendinosus muscle. 
Representative micrographs are depicted for control and after maternal inflammation 
semitendinosus cross sections (8 µm). Sections were stained for myosin heavy chain 
isoforms (red) and counterstained for desmin (green). Bar = 100 µm. 
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Figure 6. Muscle fiber-type proportions. The percentages of total fibers are presented 
for control and chronically stressed fetal semitendinosus muscle sections. Type I and 
Type IIx fibers were determined by immunohistochemistry. All sections were 
counterstained for desmin to determine total fiber numbers. 
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Figure 7. Muscle fiber cross-sectional areas presented for control and chronically 
stressed fetal semitendinosus muscle sections. Type I and Type IIx fibers were 
determined by immunohistochemistry. All sections were counterstained for desmin to 
determine total fiber numbers. *Means differ (P < 0.05) between treatment groups.  
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Figure 8. Myosin heavy chain protein content and ratio of myosin heavy chain I to 
myosin heavy chain II after chronic maternal inflammation. Electrophoretic mobility 
was used to separate MyHC-I and MyHC II fractions of total protein isolated from 
fetal extensor digitorum longus muscle.  
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Chapter 3 
 
Metabolic response of bovine myoblasts exposed to sustained β adrenergic agonist 
stimulation during in vitro differentiation 
 
Abstract. The β adrenergic agonists ractopamine HCl (β1) and zilpaterol HCl (β2) are 
commonly used as feed additives in finishing livestock to increase muscle deposition and 
decrease adipose accumulation, however the physiological mechanisms for these effects 
remain unclear. Previous studies conducted in our lab show that in adult rat skeletal 
muscle, acute stimulation with β2 agonist increases basal and insulin stimulated glucose 
oxidation in skeletal muscle from adult rats and growing lambs (Barnes et al., 2017; 
Cadaret et al., 2017b). Our objective was to determine the metabolic response of bovine 
myoblasts (muscle stem cells) differentiated in the presence of β adrenergic agonists in 
order to determine if the metabolic regulation by the β adrenergic system observed in 
skeletal muscle is contributed by muscle stem cells. Glucose uptake and glucose 
oxidation were determined in primary bovine myoblasts incubated for 4 days in 
differentiation media (2% FBS) with or without insulin, β1 adrenergic agonist, or β2 
adrenergic agonist. Incubation with insulin alone increased (P < 0.05) glucose uptake by 
~40% and oxidation by ~68% when compared to basal incubations. β2 adrenergic agonist 
alone likewise increased (P < 0.05) glucose uptake by ~54% and oxidation by ~49% from 
basal to levels that did not differ from insulin alone. β1 adrenergic agonist alone did not 
affect glucose uptake and only marginally increased (P < 0.05) glucose oxidation by 
~18% from basal. Moreover, when β1 adrenergic agonist was combined with insulin, 
glucose uptake and oxidation were less (P < 0.05) than with insulin alone. Surprisingly, 
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when β2 adrenergic agonist was combined with insulin, glucose uptake was not different 
from insulin alone but glucose oxidation was decreased (P < 0.05) compared to insulin 
alone. Together, these findings show that β2 adrenergic agonists are more effective at 
increasing metabolic efficiency in myoblasts than β1 adrenergic agonists, just as in 
mature skeletal muscle. However, these findings also show that β2 adrenergic agonists do 
not have the same effect on insulin-stimulated glucose oxidation in myoblasts as they do 
in mature muscle, indicating that the entire metabolic phenotype of mature muscle is not 
derived from the muscle stem cells, and that key aspects of adrenergic regulation of 
glucose metabolism appear to develop within the fibers themselves.   
Introduction 
β adrenergic agonists, ractopamine HCl and zilpaterol HCl, sold under the trade 
names Optaflexx  and Zilmax, respectively, enhance muscle growth and decrease fat 
accumulation in finishing cattle when used as feed additives (Mersmann, 1998). Pressure 
to increase feed efficiency due to a growing population, an increase in beef consumption, 
and competition for available land makes it beneficial for producers to use these products. 
This allows fewer resources and animals to yield more meat (Strydom, 2016) which 
benefits the U.S. agriculture economy (Centner et al., 2014). Zilpaterol HCl acts via β2 
receptors and ractopamine HCl acts primarily via β1 receptors (Lean et al., 2014). We 
have recently shown that β2 adrenergic agonists enhance metabolic efficiency by 
increasing glucose oxidation in skeletal muscle (Cadaret et al., 2017b). However, it is 
important to know whether these effects originate within muscle stem cells that will 
ultimately fuse with skeletal muscle fibers or whether they originate within the mature 
fibers themselves. After birth, skeletal muscle grows by incorporating muscle stem cells 
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called myoblasts (Schultz, 1989; Allen and Rankin, 1990). Myoblasts increase the 
myonuclear content of skeletal muscle fibers after they are activated from their quiescent 
state to proliferate, differentiate, and fuse with existing muscle fibers (Allen and 
Boxhorn, 1989; Grounds and Yablonka-Reuveni, 1993). In fact, 50-99% of a muscle 
fiber’s myonuclear content originates from myoblasts incorporated after the fiber is 
formed (Allen et al., 1979), thus myoblasts contribute greatly to the metabolic phenotype 
of the muscle. We recently found that skeletal muscle from mature rats and growing 
lambs exposed to β2 adrenergic agonist acutely and chronically, respectively, had 
increased insulin-stimulated glucose oxidation rates in culture (Barnes et al., 2017; 
Cadaret et al., 2017b). Since skeletal muscle development stems in large part from fusion 
of myoblasts, we hypothesize that this metabolic phenotype is inherited from the muscle 
stem cells via fusion with mature muscle fibers. Furthermore, differentiation of myoblasts 
in the presence of β agonists may also affect their responsiveness to β stimulation.   
Materials and Methods 
Animals. The following experiments were approved by the Institutional Animal 
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted 
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by 
the American Association for Accreditation of Laboratory Animal Care. Animals used 
for this study included four Angus-cross steers approximately one year of age that were 
humanely harvested at the UNL abattoir.    
Myoblast Isolation. At harvest, 500g of fresh semitendinosus muscle was cleaned 
of all connective tissue and fat and finely minced. Minced muscle was placed in 50 ml 
conical tubes, washed with ice-cold phosphate buffered saline (PBS, Fisher Bioreagents), 
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and centrifuged at 1,500 x g for 5 minutes at 4ºC. Pelleted tissue was re-suspended in 
PBS, and digested with protease type XIV from Strept. griseus (Sigma) at a concentration 
of 625 mg/500 ml at 37ºC for 1 hour, and centrifuged at 1,500 x g for 5 minutes. Digested 
pellets were re-suspended in warm PBS and centrifuged at 500 x g for 10, 8, and 1 
minute. After each spin, supernatant containing the myoblasts was collected, filtered, 
pelleted, and re-suspended in DMEM media. Cells were incubated in pre-plate media 
(DMEM with 10% FBS) at 37 ºC for 2 hours to remove fibroblasts. Myoblasts were 
collected, pelleted, re-suspended in freezing media (DMEM with 20% FBS and 10% 
dimethyl sulfoxide), slowly frozen, and stored in liquid nitrogen. All media constituents 
were purchased from Sigma-Aldrich except insulin, which was purchased from Eli Lilly.   
Cell Culture. Bovine myoblasts were seeded onto 12-well fibronectin-coated 
tissue culture plates for glucose uptake studies and 6-well plates for glucose oxidation 
studies at an initial seeding density of 20,000 cells per well for both studies. Cells were 
grown as previously described (Yates et al., 2014) with some modifications. Briefly, all 
plates were coated with Poly-L-Lysine and Bovine Plasma Fibronectin. Cells were 
incubated in complete growth media (78.5% DMEM, 20% FBS, 1% Ab/Am, and 0.5% 
Gentamicin) for 24 hours then incubated in differentiation media (96.5% DMEM, 2% 
FBS, 1% Ab/Am, and 0.5% Gentamicin) for four days. Differentiation media was spiked 
with one of the following treatments: no additive (basal), insulin (5 mU/ml HumulinR), 
β1 agonist (1 µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist + 
insulin, or β2 agonist + insulin (Figure 1). Differentiation media was changed every other 
day. After four days, glucose uptake and oxidation studies were performed. 
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Glucose Uptake. Cells were pre-incubated at 37ºC for 1 hour in treatment spiked 
Krebs-Henseleit Buffer (KHB) media containing 0.1% BSA, 5mM glucose, and 35 mM 
mannitol and then washed at 37ºC for 20 minutes in treatment-spiked glucose-free KHB 
media with 0.1% BSA and 40 mM mannitol. Finally, cells were incubated at 37º C for 20 
minutes in treatment-spiked KHB media with 1 mM [3H] 2-deoxyglucose (3,000 μCi/mmol) 
and 39 mM [U-14C] mannitol (12.5 µCi/mmol), and 0.1% BSA. Media was then removed and 
cells were thrice washed with sterile saline. Cultures were fixed with 4% PFA (Sigma-
Aldrich) for 20 minutes. then washed with sterile saline. Cells were nuclear stained with 
5 µg/ml Hoeshst 3342 (Thermo-Fischer) diluted in sterile saline (Vet One, Boise, Idaho). 
Cell number was estimated for each well using Olympus CellSense Software from 3 
random fields of view (area = 1.4 x 1.0 mm.). The average number of cells per field of 
view was 580. After images were captured, cells were lysed with 2 mM NaOH and lysate 
were transferred to 20 ml scintillation vials and mixed with UltimaGold scintillation 
fluid. Specific activity of [3H] in each lysate was used to estimate glucose uptake, and 
specific activity of [14C] in each lysate was used to estimate extracellular fluid volume 
using a Beckman-Coulter 1900 TA LC counter (Brea, CA). Specific activity of [3H] 2-
deoxyglucose in media was determined from three 10-µl aliquots mixed with 500-µl 
double-distilled water. All radioactive materials and scintillation fluids were purchased 
from Perkin-Elmer (Waltham, MA). Four technical replications per condition were 
performed and averaged for each animal.  
Glucose Oxidation. Myoblasts plated on one side of sealable dual-well chambers 
were used to determine glucose oxidation. Wells were imaged using Olympus CellSense 
Software just before beginning the study. Three bright-field images per well were used to 
48 
 
estimate the number of cells per well. Cells were pre-incubated at 37ºC for 1 hour in 
treatment-spiked KHB media containing 0.1% BSA and 5 mM glucose and then washed 
at 37ºC for 20 minutes in glucose-free treatment-spiked KHB media containing 0.1% 
BSA. Chambers were then sealed using greased rubber gaskets and cells were incubated 
at 37º C for 2 hours in treatment-spiked gassed (95% O2: 5% CO2) KHB media and 
containing 5 mM [14C-U] D-glucose (2.5 µCi/mmol) and 0.1% BSA. In the adjacent well 
of each sealed chamber, 2 mM NaOH was placed to capture CO2 produced. After the 
incubation period, plates were cooled for 2 minutes at -20ºC, 2M HCl was injected into 
the media through the rubber seal to release bicarbonate-bound CO2 from media and 
plates were incubated at 4ºC for 1 hour. Chambers were then opened and NaOH was 
collected and mixed with UltimaGold scintillation fluid in a 20-ml scintillation vial. 
Specific activity of 14CO2 and media were determined as described above. Background 
was determined from no-cell control chambers, and leak tests were performed by 
measuring 14CO2 in NaOH placed in adjacent chambers. Three technical replications per 
condition were averaged for each animal.  
Statistical Analysis. Data were analyzed by ANOVA using the GLM procedure of 
SAS (SAS Institute, Cary, NC). Steer was the experimental unit (n=4). Rates were 
normalized to cell number and are expressed as percentage of basal rate (mean ± standard 
error). The mean for each experimental unit is the average of four and three technical 
replications for glucose uptake and glucose oxidation, respectively. Cell numbers were 
estimated from a minimum of 133 cells per well counted over a minimum of three 
random non-overlapping fields of view. 
Results 
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Glucose Uptake. Incubation of myoblasts with insulin alone increased (P < 0.05) 
glucose uptake by ~40% compared to basal incubations (Figure 2). Incubation with β2 
adrenergic agonist alone also increased (P < 0.05) glucose uptake by ~54% compared to 
basal. Conversely, incubation with β1 adrenergic agonist alone had no effect on glucose 
uptake compared to basal. Furthermore, glucose uptake in myoblasts that were co-
incubated with β1 adrenergic agonist and insulin or with β2 adrenergic agonist and 
insulin was not different from myoblasts incubated with insulin alone. 
Glucose Oxidation. Incubation of myoblasts with insulin alone increased (P < 
0.05) glucose oxidation by ~68% compared to basal (Figure 3). Incubation with β2 
adrenergic agonist alone also increased (P < 0.05) glucose oxidation by ~49% when 
compared to basal. Conversely, incubation with β1 adrenergic agonist alone had no effect 
on glucose oxidation. Furthermore, co-incubation with insulin and β1 agonist or with 
insulin and β2 agonist decreased glucose oxidation when compared to insulin alone. 
Incubation with β2 agonist alone increased glucose oxidation when compared to 
incubation with β1 agonist alone. In addition, co-incubation with insulin and β1 agonist 
was no different than co-incubation with insulin and β2 agonist.   
Discussion 
In this study, we show that glucose uptake and oxidation rates are increased when 
myoblasts are differentiated in the presence of β2 adrenergic stimulation when compared 
to β1 adrenergic stimulation or no stimulation. This indicates that β2-specific adrenergic 
activity increases glucose metabolic efficiency in differentiated myoblasts similar to its 
effects in skeletal muscle. Conversely, β2 adrenergic stimulation reduced insulin-
stimulated glucose oxidation rates, which  is opposite of the effect on skeletal muscle 
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during acute stimulation (Cadaret et al., 2017b). This indicates that the interaction 
between insulin and β agonists is different in myoblasts after sustained exposure during 
differentiation than it ultimately is in the mature fibers themselves. This difference could 
be due to sensitivity differences that exist between myoblasts and skeletal muscle or due 
to changes brought on by the longer exposure time in the present study. 
Stimulation by β2 adrenergic agonist alone increased metabolic efficiency in 
myoblasts when compared to stimulation by β1 adrenergic agonist alone. We postulate 
that this is due to differences in metabolic pathways affected by each of these adrenergic 
agonists. Glucose oxidation was increased in myoblasts stimulated with the β2 adrenergic 
agonist, however, glucose oxidation was not affected by the β1 adrenergic agonist. This 
suggests that the β1 adrenergic agonist does not stimulate glucose oxidation and thus may 
be stimulating other metabolic pathways such as fatty acid mobilization in order to 
contribute to skeletal muscle gain efficiency observed in feedlot animals 
In bovine myoblasts, β2 adrenergic stimulation decreased insulin-stimulated 
metabolic efficiency. However, stimulation of adult rat skeletal muscle with β2 
adrenergic agonists and insulin increased insulin-stimulated metabolic efficiency 
(Cadaret et al., 2017b). This indicates that β2 agonist and insulin interactions in mature 
muscle fibers are not necessarily derived from the muscle stem cells. Furthermore, it is 
also important to note that the bovine myoblasts were chronically exposed to the β 
adrenergic stimulation since they were differentiated for 4 days in treatment-spiked 
media, whereas the adult rat skeletal muscle had only been acutely exposed (~4 hours) to 
the β adrenergic agonists. This could indicate that chronic exposure desensitizes β2 
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adrenergic receptors in differentiating myoblasts, thus contributing to the decrease in 
insulin-stimulated glucose oxidation. 
Differentiation of myoblasts in the presence of β1 adrenergic agonist, had no 
effect on either glucose uptake or oxidation rates. This indicates that the β1 adrenergic 
agonist functions through different metabolic pathways than β2 adrenergic agonist to 
enhance muscle development and decrease lipid accumulation which may or may not 
involve changes in metabolic efficiency. However, β1 adrenergic stimulation reduced the 
ability of insulin to stimulate glucose oxidation. Chronic exposure to epinephrine is 
known to decrease insulin sensitivity (Deibert and Defronzo, 1980), and our findings 
would indicate that this is primarily due to β1 specific activity. Together, our findings 
demonstrate that zilpaterol HCl is more effective at increasing metabolic efficiency 
compared to ractopamine HCl, and that the beneficial effects of ractopamine HCl on 
muscle growth efficiency occur through some other physiological mechanism.  
In conclusion, our study shows similarities as well as notable differences in 
responsiveness to β adrenergic stimulation between differentiated myoblasts and mature 
skeletal muscle. Most notably, β2 adrenergic stimulation had opposite effects on insulin-
stimulated glucose oxidation in differentiated myoblasts in the present study as 
previously observed in mature skeletal muscle. This indicates that these interacting 
regulatory responses develop in the mature fiber and are not necessarily a phenotypic trait 
derived from muscle stem cells during fusion. Nevertheless, β2-stimulated glucose 
oxidation in our differentiated myoblasts paralleled stimulation in mature skeletal muscle, 
and β1 adrenergic stimulation had little to no effect on myoblasts, similar to our previous 
observations in skeletal muscle.  
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Differentiation 
Media 
Constituents 
1 Basal DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin  
2 Insulin DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin + 5 mU/ml 
HumulinR 
3 β1 DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin + 1 μM 
ractopamine HCl 
4 β2 DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin  + 0.05 μM 
zilpaterol HCl 
5 β1 + 
Insulin 
DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin +  β1 + Insulin 
6 β2 + 
Insulin 
DMEM + 2% FBS + 1% Ab/Am + 0.5% Gentamicin +  β2 + Insulin 
Figure 1. Components of differentiation media for bovine myoblasts. 
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Figure 2.  Schematic of glucose uptake study (A) and results of glucose uptake (B) in 
primary bovine myoblasts during 20 minute incubation after differentiation with one 
of the following treatments: No additive (basal), insulin (5 mU/ml HumulinR), β1 
agonist (1 µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist + 
insulin, or β2 agonist + insulin. a,b,c means with different superscripts differ (P ≤ 0.05).  
Pre-incubation 
60-min. 
Wash incubation 
20-min. 
Glucose uptake incubation 
20-min. 
KHB media: 
1) 0.1% BSA 
2) 5 mM glucose 
3)35 mM mannitol 
KHB media: 
1) 0.1% BSA 
2) 0 mM glucose 
3) 40 mM 
mannitol 
 
KHB media: 
1) 0.1% BSA 
2) 1 mM [
3
H] 2-
deoxyglucose 
3) 39 mM [U-
14
C] mannitol  
A. 
B. 
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Figure 3. Schematic of glucose oxidation study (A) and results of glucose oxidation 
(B) in bovine myoblasts during a 120 minute incubation after differentiation with the 
following treatments: No additive (basal), insulin (5 mU/ml HumulinR), β1 agonist (1 
µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist + insulin, or 
β2 agonist + insulin. a,b,c,d means with different superscripts differ (P ≤ 0.05). 
Wash 
incubation 
20-min. 
Glucose 
oxidation 
incubation 
120-min. 
Incubation at -
20ºC 
2-min. 
KHB media: 
1) 0.1% BSA 
2) 5 mM 
glucose 
KHB media: 
1) 0.1% BSA 
2) 0 mM 
glucose 
KHB media: 
1) 0.1% BSA 
2) 5 mM [U-
14
C] 
D-glucose  
Pre-incubation 
60-min. 
End of metabolic 
activity 
1 M HCL added 
to media 
Incubation at 4ºC 
2-hr. 
A. 
B. 
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Chapter 4 
Oxidative capacity in myoblasts from high and low androstenedione cows 
 
Abstract. Calves born to cows classified as having elevated follicular fluid 
concentrations of androstenedione (A4; High A4) have increased weaning weights 
compared to control Low A4 cows. However, the underlying mechanisms causing the 
increased weaning weights in calves born to High A4 cows is unknown. Our objective 
was to determine whether myoblasts isolated from High A4 cows had increased 
metabolic efficiency compared to myoblasts from Low A4 cows, which may help to 
explain the increase in weight gain in calves born to High A4 cows. For this study, 
myoblasts were isolated from the oblique of ten composite beef cows that were classified 
as having High (n=5; A4 ≥ 40 ng/ml) or Low (n=5; A4 ≤ 20 ng/ml) A4 concentrations. 
Myoblasts were incubated in complete growth media for 48 hours then incubated in 
treatment-spiked XF base medium containing either no additive (basal), 1 mU/ml insulin, 
or 10 mU/ml insulin. A mitochondrial stress test was performed on the myoblast cultures 
to measure oxygen consumption rate (OCR) as a proxy for mitochondrial respiration and 
extra-cellular acidification rate (ECAR) as a proxy for glycolysis. Serial injection of 
Oligomycin, FCCP, and Rotenone were utilized during the mitochondrial stress test to 
uncouple mitochondrial oxygen consumption and inhibit ATP production. This study 
showed no differences in mitochondrial respiration among A4 groups but a tendency for 
greater (P = 0.1) glycolysis in High A4 myoblasts incubated in basal conditions and in 
Low A4 myoblasts incubated with 1 mU/ml insulin. Moreover, OCR for basal respiration 
and for ATP production were greatest (P < 0.05) in the absence of insulin and were 
reduced similarly by 1 and 10 mU/ml insulin. Together, these results show that the 
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greater weaning weights in the High A4 population do not appear to be due to greater 
muscle metabolic efficiency.  
Introduction 
A population of cows within the University of Nebraska-Lincoln herd were 
classified as having high androstendione (A4) concentrations within their follicular fluid 
(Summers et al., 2014). Elevated concentrations of androgens is a hallmark of polycystic 
ovary syndrome (PCOS), which is known to decrease fertility rates (Franks, 2006). In 
fact, the cows identified as having High A4 concentrations had a 17% reduction in 
calving rates (Summers et al., 2014). Furthermore, elevated maternal androgen levels 
during gestation are known to impair fetal growth, leading to reduced birth weight 
(Carlsen et al., 2006), and lead to metabolic deficiencies into adult life (Smith et al., 
2009). Interestingly, calves that were born to cows classified as having High A4 
concentrations had greater weaning weights than calves born to Low A4 cows by 12 kg. 
(Summers et al., 2014). This indicates that metabolic adaptations to the physiological 
state of High A4 cows may be occurring during gestation. In addition to decreased 
fertility rates, a well characterized factor seen in patients with PCOS is altered 
metabolism leading to insulin resistance and obesity (Dunaif et al., 1989; Legro, 2000). 
We speculate that A4 may be acting in one of two ways. First, A4 may stimulate similar 
anabolic effects as testosterone, leading to an increase in skeletal muscle mass in the 
growing calf. Secondly, A4 may antagonize the effects of testosterone, and chronic in 
utero exposure to a High A4 environment may lead to a desensitization of skeletal muscle 
to A4, thus reducing its antagonist effect.    
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The mitochondrial electron transport chain consists of a series of redox reactions 
that reduce NADH using oxygen to form H2O and ATP (Turrens and Boveris, 1980). 
There are 4 complexes within the electron transport chain in addition to an ATP synthase 
complex (Zhang et al., 1990). During a mitochondrial stress test, different compounds 
including Oligomycin, FCCP, and Rotenone are introduced into a cell culture 
sequentially to shut down complexes in the electron transport chain in order to measure 
specific components of oxygen consumption rate (OCR) (Figure1). Injection of 
Oligomycin into media blocks ATP synthesis by shutting down the ATP synthase 
complex of the electron transport chain (Nicholls et al., 2010). Consequentially, oxygen 
is maximally consumed by Complex IV. By measuring OCR before and after Oligomycin 
has been injected, the fraction of oxygen consumed during ATP synthesis and fraction 
needed to overcome proton leak can be determined. The second compound injected into 
the media is FCCP which uncouples ATP production, leading to rapid energy and oxygen 
consumption without the production of ATP. Thus, OCR and extra-cellular acidification 
rate (ECAR) increase because the cell will attempt to maintain energy balance by 
utilizing glycolysis for ATP generation. The last compound to be injected during the 
study is Rotenone, which inhibits Complex I. This shuts down the electron transport 
chain, inhibiting mitochondrial respiration and allowing both mitochondrial and non-
mitochondrial fractions that contribute to respiration to be measured (Nicholls et al., 
2010). By measuring OCR after each compound is added, cellular oxidation of total 
substrates (amino acids, lipids, and carbohydrates) can be determined. Furthermore, 
measurement of ECAR allows cellular glycolysis to be measured. The objective of this 
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study was to determine whether the increased weaning weights of the calves born to High 
A4 cows is a result of increased muscle metabolic efficiency in this population. 
Materials and Methods 
Animals. The following experiments were approved by the Institutional Animal 
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted 
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by 
the American Association for Accreditation of Laboratory Animal Care. Animals used 
for this study included ten composite beef cows [25% MARC III (25% Angus, 25% 
Hereford, 25% Pinzgauer, 25% Red Poll)]. 
Androstenedione Classification. Follicular fluid A4 concentrations were 
determined as previously described (Summers et al., 2014). Follicular fluid A4 
concentrations were determined using a human A4 ELISA kit (Alpha Diagnostics 
International, San Antonio, TX). Inter- and intra- assay of variation for A4 coefficients 
were 6.5% and 5.7% respectively. The cows were classified as High (≥ 40 ng/ml A4) or 
Low (≤ 20 ng/ml) A4 based on dominant A4 concentration for follicle aspiration at 
ovariectomy procedures.   
Myoblast Isolation. During ovariectomy, muscle from the oblique was collected 
and cleaned of all connective tissue and fat, and then finely minced. Minced muscle was 
placed 50 ml conical tubes, washed with ice-cold phosphate buffered saline (PBS, Fischer 
Bioreagents) and centrifuged at 1,500 x g for 5 minutes. Pelleted tissue was re-suspended 
in PBS, digested with protease type XIV from Strept. griseus (Sigma) at a concentration 
of 625 mg/500 ml PBS at 37ºC for 1 hour, and centrifuged at 1,500 x g for 5 minutes. 
Digested pellets were re-suspended in warm PBS and centrifuged 3 times at 500 x g for 
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10, 8, and 1 minute. Supernatant containing myoblasts was collected after each spin. 
These cells were incubated at 37ºC in pre-plate media (DMEM with 10% FBS) for 2 
hours to remove fibroblasts. Cells were then re-suspended in freezing media (CGM + 
10% dimethyl sulfoxide) and stored in liquid nitrogen. All media constituents were 
purchased from Sigma-Aldrich except insulin, which was purchased from Eli Lilly.   
Cell Culture. Isolated bovine myoblasts were seeded onto 24-well XFe24 Cell 
Culture Microplates (Seahorse Bioscience, North Billerica, MA) at an initial seeding 
density of 5,000 cells per well. Four background correction wells were seeded with no 
cells. Cells were grown as previously described (Yates et al., 2014) with some 
modifications. Briefly, all plates were coated with Poly-L-Lysine and Bovine Plasma 
Fibronectin. Cells were incubated at 37ºC and 5% CO2 in complete growth media (78.5% 
DMEM, 20% FBS, 1% Ab/Am, and 0.5% Gentamicin) for 48 hours.  
 XF Assay Mito Stress Test. After 48 hour incubation in complete growth media, 
cells were washed twice with XF Base Media (Seahorse Bioscience) containing 25 mM 
glucose, 1.0 mM pyruvate, and 2 mM L-glutamine. The medium was then spiked with no 
additive (basal), 1 mU/ml insulin (Humulin-R), or 10 mU/ml insulin. 500 µl of XF Base 
Medium with the previously described additives were added to each well and cells were 
incubated at 37ºC in a non-CO2 incubator for 1 hour. A cell mito stress test was run on 
the plate using the Seahorse XF-96 instrument (Seahorse Bioscience). 1.0 µM 
oligomycin, 1.0 µM FCCP, and 0.5 µM rotenone were sequentially injected to determine 
ATP-linked respiration, maximal respiration, and non-mitochondrial respiration, 
respectively. These parameters along with basal respiration were used to determine 
proton leak and respiration capacity.  
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BCA Protein Assay. Following the mito stress test, total protein of cells was 
determined in each well using a Pierce BCA Protein Assay Kit (Thermo Fisher, 
Waltham, MA). XF base media was aspirated from wells and 75 µl of RIPA buffer 
(Thermo Fisher) was added to each well. A sterile p200 pipette tip was used to scrape 
cells from the bottom of each well. 10 µl of each prepared serial dilution of albumin 
standard and each sample were added in triplicates to a 96-well plate followed by 200 µl 
of working solution. Plate was mixed thoroughly on a shaker for 30 seconds and 
incubated at 37ºC for 30 minutes. Absorbance was then measured at 562 nm on an 
EPOCH plate reader (Bio Tek, Winooski, VT) and analyzed using GEN5 software (Bio 
Tek).  
Statistical Analysis. Data were analyzed using ANOVA output of SAS (SAS 
Institute, Cary, NC) as a 2x3 factorial. High vs. Low A4 was the main effect, and insulin 
concentration and A4*insulin interaction was in the subplot interaction. Cow was the 
experimental unit (N=10). The mean for each experimental unit is the average of 6 
technical replications per insulin concentration for OCAR and ECAR. For each well, 
OCR and ECAR were normalized to amount of total protein. Means for each 
measurement period are the average of three measurements taken 5 minutes apart. Data 
are presented as means ± standard error.  
Results 
For this study, OCR (Figure 2) was measured in bovine myoblasts. There were 
not differences among A4 groups for basal respiration rate, ATP production, or maximal 
ATP production for OCR (Figure 3). Similarly, there were not differences among A4 
groups for any measurements taken after each inhibitory compound was injected into the 
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media for OCR. In addition, ECAR (Figure 4) was measured and there were not 
differences among A4 groups for glycolytic capacity (Figure 5). However, the myoblasts 
from High A4 cows incubated at basal and Low A4 cows incubated with 1 mU/ml of 
insulin tended to have increased (P = 0.1) glycolysis after injection of Oligomycin. There 
were no differences among treatments for any other measurements taken after FCCP or 
Rotenone were injected into the media for ECAR.  
Discussion 
In this study, we did not find any differences in OCR between myoblasts isolated 
from High A4 and Low A4 cows, suggesting that mitochondrial respiration and thus ATP 
production from oxidation is similar between High and Low A4 cows. Furthermore, 
myoblasts from High A4 cows in the absence of insulin and myoblasts from Low A4 
cows in the presence of insulin had a tendency for increased glycolytic rates.  
The OCR between the High and Low A4 cows was similar, indicating that 
cellular oxygen consumption rate among treatments was not different. Since oxygen is 
being consumed at a similar rate among treatments, it suggests that carbohydrates, amino 
acids, and lipids are being oxidized at similar rates. Furthermore, the addition of 
inhibitory compounds such as Oligomycin, FCCP, and Rotinone had similar affects 
among treatments which also suggests that oxidation rates are not different among 
groups. Adaptations occurring during gestation or other growth advantages that lead to 
increased weaning weights in High A4 cattle populations are likely not derived from 
enhanced metabolic efficiency in muscle from the cow.  
A major role of insulin in metabolism is to stimulate uptake of glucose into cells 
where it can be metabolized by one of several pathways, including anaerobic glycolysis. 
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The treatments had similar glycolytic capacities but myoblasts from High A4 cows in the 
absence of insulin and Low A4 cows when insulin was present had a tendency for 
increased glycolytic rates. This was determined by increased acidification in cell media 
resulting from lactate production, a byproduct of glycolysis.  
We hypothesized that myoblasts from the High A4 cows would have increased 
metabolic efficiency compared to myoblasts from the Low A4 cows which would help to 
explain greater pre-weaning growth in this population. However, we saw no differences 
in skeletal muscle oxidative metabolic efficiency. This suggests that the increased 
weaning weights seen in the calves from cows classified as High A4 is due to a different 
molecular mechanism than postulated. However, additional studies that take a closer look 
at the metabolic efficiency of the skeletal muscle from the calves themselves may help 
clarify gaps in our understanding of the underlying mechanism that leads to their 
increased weaning weights.  
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Figure 1. Components of mitochondrial respiration (A). Oxygen consumption rate in 
bovine myoblasts from High and Low A4 cows incubated with either basal, 1 mU/ml, 
or 10 mU/ml of insulin. Each mean is the average of three measurements taken during 
the period (B). 
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Figure 3. Oxygen consumption for basal respiration (A), ATP production (B), and 
ATP production normalized to basal (C) in bovine myoblasts from High and Low A4 
cows incubated with either basal, 1 mM/ml, or 10 mM/ml of insulin. 
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Figure 4. Components of glycolysis (A) and extra-cellular acidification (ECAR) rates 
in bovine myoblasts from High and Low A4 cows incubated with either basal, 1 
mU/ml, or 10 mU/ml of insulin (B). 
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Figure 5. Glycolysis (A) and glycolytic capacity (B) in bovine myoblasts from High and 
Low A4 cows incubated with either basal, 1 mU/ml, or 10 mU/ml of insulin. *Means 
tend to differ (P ≤ 0.10) between A4 groups within insulin concentrations.  
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